The median bPFS of this group was 17.6 months after stopping ADT; however, compared with those not treated with ADT, the differences in bPFS did not reach statistical significance ( P = .21; Fig. 2 ).
← all excerpts
Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate Cancer.
2
0.2100
0.2100
The sentences
8 – 15 Collectively, these results have led to an increasing trend to treat oligometastatic lesions with MDT to improve OS and PFS, delay initiation of systemic therapies with unfavorable toxicity profiles, and offer treatment breaks for individuals amassing toxicity from systemic therapy.